2050 Capital is an early stage deep technology and science investment organisation. We invest in transformative and defensible innovation that impacts large fundamental sectors.
We focus on enterprise software, biotech, and engineering and science ventures. We believe that to excercise significant positive change one must invest significant time and effort. No shortcuts. Our investment approach is surgical, backed by deep due dilgence. We close 2-6 deals per year. We write $200-500k seed checks and up to $3m in follow-ons. From the 1st check onward we assist our portfolio companies with business development, strategy, and next stage fundraising. Once we become your investors, we become your partners.
If you have audacious, nearly impossible goals, we'd love to get to know you.